Skip to main content
SpringerLink
Log in

Grundlagen der Neuro-/Psychopharmakologie

  • Chapter
  • First Online:
Neuro-/Psychopharmaka im Kindes- und Jugendalter

  • 6248 Accesses

Zusammenfassung

In diesem Kapitel werden zunächst wichtige Grundbegriffe der Neuro-/Psychopharmakologie erklärt und allgemeine Fragen der Arzneimittelwirkungen besprochen. Weiterhin werden Prinzipien der Neurotransmission, wichtige Neurotransmittersysteme sowie molekulare Strukturen im Gehirn als Angriffspunkte von Neuro-/Psychopharmaka beschrieben, um Wirkungen von zentral aktiven Arzneimitteln im Gesamtzusammenhang zu begreifen.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur

Weiterführende Literatur

  • Aktories K, Förstermann U, Hofmann FB, Starke K (2013) Allgemeine und spezielle Pharmakologie und Toxikologie, 11. Aufl. Urban & Fischer, München

    Google Scholar 

  • Brady S, Siegel GJ, Albers RW, Price DL (2012) Basic neurochemistry. Principles of molecular, cellular, and medical neurobiology, 8. Aufl. Academic Press, Oxford

    Google Scholar 

  • Kandel ER, Schwartz JH, Jessel TM, Siegelbaum SA, Hudspeth AJ (2012) Principles of neural science, 5. Aufl. McGraw-Hill, New York

    Google Scholar 

  • Mutschler E, Geisslinger G, Kroemer HK, Menzel S, Ruth P (2012) Mutschler Arzneimittelwirkungen. Pharmakologie – Klinische Pharmakologie – Toxikologie, 10. Aufl. Wissenschaftliche Verlagsgesellschaft, Stuttgart

    Google Scholar 

  • Palmer M, Chan A, Dieckmann T, Honek J (2012) Biochemical pharmacology. Wiley, Hoboken

    Google Scholar 

  • Schatzberg AF, Nemeroff CB (2009) The American psychiatric publishing textbook of psychopharmacology, 4. Aufl. American Psychiatric Publishing, Arlington

    Google Scholar 

  • Squire LR, Berg D, Bloom FE, du Lac S, Ghosh A, Spitzer NC (2012) Fundamental neuroscience, 4. Aufl. Academic Press, Oxford

    Google Scholar 

Zitierte Literatur

  • Albuquerque EX, Pereira EF, Alkondon M, Rogers SW (2009) Mammalian nicotinic acetylcholine receptors: from structure to function. Physiol Rev 89:73–120

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Alexander SPH, Benson HE, Faccenda E et al (2013a) The concise guide to pharmacology 2013/14: G protein-coupled receptors. Br J Pharmacol 170:1459–1581

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Alexander SPH, Benson HE, Faccenda E et al (2013b) The concise guide to pharmacology 2013/14: ligand-gated ion channels. Br J Pharmacol 170:1582–1606

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Alexander SPH, Benson HE, Faccenda E et al (2013c) The concise guide to pharmacology 2013/14: transporters. Br J Pharmacol 170:1706–1796

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Azevedo FAC, Carvalho LRB, Grinberg LT et al (2009) Equal numbers of neuronal and nonneuronal cells make the human brain an isometrically scaled-up primate brain. J Comp Neurol 513:532–541

    Article  PubMed  Google Scholar 

  • Barbeau A, Sourkes TL, Murphy GF (1962) Les catecholamines dans la maladie de Parkinson. In: de Ajuriaguerra J (Hrsg) Monoamines et système nerveux central. Masson, Paris, S 247–262

    Google Scholar 

  • Barnes NM, Sharp T (1999) A review of central 5-HT receptors and their function. Neuropharmacology 38:1083–1152

    Article  CAS  PubMed  Google Scholar 

  • Baumeister AA, Hawkins MF, Uzelac SM (2003) The myth of reserpine-induced depression: role in the historical development of the monoamine hypothesis. J Hist Neurosci 12:207–220

    Article  PubMed  Google Scholar 

  • Bear MF, Connors BW, Paradiso MA (2009) Neurowissenschaften. Ein grundlegendes Lehrbuch für Biologie, Medizin und Psychologie, 3. Aufl. Spektrum, Heidelberg, S 183 (Deutsche Ausgabe herausgegeben von A.K. Engel)

    Google Scholar 

  • Beaulieu J-M, Gainetdinov RR (2011) The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol Rev 63:182–217

    Article  CAS  PubMed  Google Scholar 

  • Birkmayer W, Hornykiewicz O (1961) Der L-Dioxyphenylalanineffekt bei der Parkinson-Akinese. Wien Klin Wschr 73:787–788

    CAS  PubMed  Google Scholar 

  • Blackwell B, Marley E, Price J, Taylor D (1967) Hypertensive interactions between monoamine inhibitors and foodstuffs. Brit J Psychiatr 113:349–365

    Article  CAS  Google Scholar 

  • Broese M, Riemann D, Hein L, Nissen C (2012) alpha-Adrenergic receptor function, arousal and sleep: Mechanisms and therapeutic implications. Pharmacopsychiatry 45:209–216

    Article  CAS  PubMed  Google Scholar 

  • Clark AJ (1937) Individual variation in response to drugs. Br Med J 2:307–310

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cohen J (1988) Statistical power analysis for the behavioral sciences, 2. Aufl. Erlbaum, Hillsdale, NJ

    Google Scholar 

  • Crane GE (1957) Iproniazid (Marsilid) phosphate: a therapeutic agent for mental disorders and debilitating diseases. Psychiatr Res Rep Am Psychiatr Assoc 8:142–152

    CAS  PubMed  Google Scholar 

  • Dean B (2002) Changes in the molecular structure of the brain in bipolar disorder: findings using human postmortem brain tissue. World J Biol Psychiatry 3:125–132

    Article  PubMed  Google Scholar 

  • Ernst E, Vögtli A (2010) Moderne Pharmakokinetik. Wiley-VCH, Weinheim, S 3

    Google Scholar 

  • Freis ED (1954) Mental depression in hypertensive patients treated for long periods with large doses of reserpine. N Engl J Med 251:1006–1008

    Article  CAS  PubMed  Google Scholar 

  • Gerlach M, Riederer P (2002) Monoamin-Oxidase-Hemmer: Einteilung. In: Riederer P, Laux G, Pöldinger W (Hrsg) Neuro-Psychopharmaka, Antidepressiva, Phasenprophylaktika und Stimmungsstabilisierer, 2. Aufl. Bd. 3. Springer, Wien, S 437–441

    Google Scholar 

  • Gerlach M, Gsell W, Kornhuber J et al (1996) A post mortem study on neurochemical markers of dopaminergic, GABA-ergic and glutamatergic neurons in basal ganglia-thalamocortical circuits in Parkinson syndrome. Brain Res 741:142–152

    Article  CAS  PubMed  Google Scholar 

  • Gerlach M, Reichmann H, Riederer P (2007) Die Parkinson-Krankheit. Grundlagen, Klinik, Therapie, 4. Aufl. Springer, Wien

    Book  Google Scholar 

  • Girault JA, Greengard P (2004) The neurobiology of dopamine signaling. Arch Neurol 61:641–644

    Article  PubMed  Google Scholar 

  • Hassel B, Dingledine (2005) Glutamate. In: Siegel GJ, American Society for Neurochemistry, Albers RW, Brady S, Price DL (Hrsg) Basic neurochemistry. Molecular, cellular and medical aspects, 7. Aufl. Academic Press, London, S 270

    Google Scholar 

  • Heal DJ, Smith SL, Gosden J, Nutt DJ (2013) Amphetamine, past and present – a pharmacological and clinical perspective. J Psychopharmacol 27:479–496

    Article  PubMed  PubMed Central  Google Scholar 

  • Hiemke C, Baumann P, Stingl J (2012) Pharmakokinetik, Pharmakogenetik und therapeutisches Drug Monitoring. In: Gründer G, Benkert O (Hrsg) Handbuch der psychiatrischen Pharmakotherapie, 2. Aufl. Springer, Berlin, S 441–464

    Google Scholar 

  • Huot P, Fox SH, Brotchie JM (2011) The serotonergic system Parkinson’s disease. Progr Neurobiology 95:163–212

    Article  CAS  Google Scholar 

  • Kenakin T (2004) Principles: Receptor theory in pharmacology. Trends Pharmacol Sci 25:186–192

    Article  CAS  PubMed  Google Scholar 

  • Kearns GL, Abdel-Rahman SM, Alander SW, Blowey DL, Leeder JS, Kauffman RE (2003) Delopmental pharmacology – drug disposition, action, and therapy in infants and children. N Engl J Med 349:1157–1167

    Article  CAS  PubMed  Google Scholar 

  • Kirchheiner J, Rodriguez-Antona C (2009) Cytochrome P450 2D6 genotyping. Potential role in improving treatment outcomes in psychiatric disorders. CNS Drugs 23:181–191

    Article  CAS  PubMed  Google Scholar 

  • Labarca C, Nowak MW, Zhang H, Tang L, Deshpande P, Lester HA (1995) Channel gating governed symmetrically by conserved leucine residues in the M2 domain of nicotinic receptors. Nature 376:514–516

    Article  CAS  PubMed  Google Scholar 

  • Laupacis A, Sackett DL, Roberts RS (1988) An assessment of clinically useful measures of the consequences of treatment. N Engl J Med 318:1728–1733

    Article  CAS  PubMed  Google Scholar 

  • Lopez-Munoz F, Alamo C, Cuenca E, Shen WW, Clervoy P, Rubio G (2005) History of the discovery and clinical introduction of chlorpromazine. Ann Clin Psychiatry 17:113–135

    Article  PubMed  Google Scholar 

  • Madras BK, Miller GM, Fischman AJ (2005) The dopamine transporter and attention-deficit/hyperactivity disorder. Biol Psychiat 57:1397–1409

    Article  CAS  PubMed  Google Scholar 

  • Murphy DL, Li W, Engel S, Wichems C, Andrews A, Lesch K-P, Uhl G (2001) Genetic perspectives on the serotonin transporter. Brain Res Bull 56:487–494

    Article  CAS  PubMed  Google Scholar 

  • Mutschler E, Geisslinger G, Kroemer HK, Ruth P, Schäfer-Korting M (2008) Mutschler Arzneimittelwirkungen, 9. Aufl. Wissenschaftliche Verlagsgesellschaft, Stuttgart, S 5

    Google Scholar 

  • Mutschler E, Geisslinger G, Kroemer HK, Menzel S, Ruth P (2012) Mutschler Arzneimittelwirkungen. Pharmakologie – Klinische Pharmakologie – Toxikologie, 10. Aufl. Wissenschaftliche Verlagsgesellschaft, Stuttgart

    Google Scholar 

  • Nicholas AP, Hökfelt T, Pieribone PA (1996) The distribution and significance of CNS adrenoreceptors examined with in situ hybridization. Trends Pharmacol Sci 17:245–255

    Article  CAS  PubMed  Google Scholar 

  • Olney JW (1978) Neurotoxicity of excitatory amino acids. In: McGeer EG, Olney JW (Hrsg) Kainic acid as a tool in neurobiology. Raven Press, New York, S 95–121

    Google Scholar 

  • Pupo A, Minneman K (2001) Adrenergic pharmacology: focus on the central nervous system. CNS Spectr 6:656–662

    CAS  PubMed  Google Scholar 

  • Quiedeville A, Boulouard M, Da Silva Costa-Aze V, Dauphin F, Bouet V, Freret (2014) 5-HT6 receptor antagonists as treatment for age-relatd cognitive decline. Rev Neurosci 25:417–427

    Article  CAS  PubMed  Google Scholar 

  • Riederer P, Youdim MBH (1986) Monoamine oxidase activity and monoamine metabolism in brains of parkinsonian patients treated with L-deprenyl. J Neurochem 46:1359–1365

    Article  CAS  PubMed  Google Scholar 

  • Root DH, Mejias-Aponte CA, Zhang SL, Wang HL, Hoffman AF, Lupica CR, Morales M (2014) Single rodent mesohabenular axons release glutamate and GABA. Nat Neurosci 17:1543–1551

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sallee F, Connor DF, Newcorn JH (2013) A review of the rational and clinical utilization of α2-adrenoceptor agonists for the treatment of attention-deficit/hyperactivity and related disorders. J Child Adol Psychop 23:308–319

    Article  CAS  Google Scholar 

  • Schwenk J, Metz M, Zolles G et al (2010) Native GABAB receptors are heteromultimers with a family of auxiliary subunits. Nature 464:231–235

    Article  Google Scholar 

  • Snyder SH (2002) Forty years of neurotransmitters. A personal account. Arch Gen Psychiatry 59:983–994

    Article  CAS  PubMed  Google Scholar 

  • Starke K (2005) Allgemeine Pharmakologie und Toxikologie. Grundbegriffe. In: Aktories K, Förstermann U, Hofmann FB, Starke K (Hrsg) Allgemeine und spezielle Pharmakologie und Toxikologie, 9. Aufl. Urban & Fischer, München, S 1–5

    Google Scholar 

  • Taylor P, Brown JH (2005) Acetylcholine. In: Siegel GJ, American Society for Neurochemistry, Albers RW, Brady S, Price DL (Hrsg) Basic neurochemistry. Molecular, cellular and medical aspects, 7. Aufl. Academic Press, London, S 187

    Google Scholar 

  • Torres GE, Gainetdinov RR, Caron MG (2003) Plasma membrane monoamine transporters: Structure and function. Nat Rev Neurosci 4:13–25

    Article  CAS  PubMed  Google Scholar 

  • Watling KJ (2006) The Sigma-RBI handbook of receptor classification and signal transduction, 5. Aufl. Sigma-RBI, Natick

    Google Scholar 

  • Waxham MN (2003) Neurotransmitter receptors. In: Squire LR, Bloom FE, McConnell SK, Roberts JL, Spitzer NC, Zigmond MJ (Hrsg) Fundamental neuroscience, 2. Aufl. Academic Press, London, S 225–258

    Google Scholar 

  • Weber MW (2012) Die moderne Psychopharmakologie aus wissenschaftshistorischer Sicht. In: Gründer G, Benkert O (Hrsg) Handbuch der psychiatrischen Pharmakotherapie, 2. Aufl. Springer, Berlin, S 23–36

    Google Scholar 

  • Zimmer L, Billard T (2014) Molecular imaging of the serotonin 5-HT7 receptors: from autoradiography to positron emission tomography. Rec Neurosci 25:357–365

    CAS  Google Scholar 

  • Zimmermann H (1993) Synaptic transmission. Cellular and molecular basis. Thieme, Oxford, S 75

    Google Scholar 

  • Zohar J, Nutt DJ, Kupfer DJ, Möller H-J, Yamawaki S, Spedding M, Stahl SM (2014) A proposal for an updated neuropsychopharmacological nomenclature. Eur Neuropsychopharmacol 24:1005–1014

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik und Poliklinik für Kinder- u. Jugendpsychiatrie, Psychosomatik u. Psychotherapie, Universitätsklinikum Würzburg, Zentrum für Psychische Gesundheit, Füchsleinstraße 15, 97080, Würzburg, Deutschland

    Dr. rer. nat. Carsten Drepper & Prof. Dr. rer. nat. Manfred Gerlach

Authors
  1. Dr. rer. nat. Carsten Drepper
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Prof. Dr. rer. nat. Manfred Gerlach
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Manfred Gerlach .

Editor information

Editors and Affiliations

  1. Zentrum für Seelische Gesundheit, Universitätsklinikum Würzburg, Würzburg, Germany

    Manfred Gerlach

  2. Privatklinik für Seelische Gesundheit, J, HEMERA Klinik, Bad Kissingen, Germany

    Claudia Mehler-Wex

  3. Zentrum für Kinder- und Jugendpsychiatri, Universität Zürich, Zürich, Zürich, Switzerland

    Susanne Walitza

  4. Zentrum für Seelische Gesundheit, Universitätsklinikum Würzburg, Würzburg, Bayern, Germany

    Andreas Warnke

  5. Abteilung Kinder Jugendpsychiatrie, Kliniken der Stadt Köln gGmbH, Köln, Germany

    Christoph Wewetzer

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Drepper, C., Gerlach, M. (2016). Grundlagen der Neuro-/Psychopharmakologie. In: Gerlach, M., Mehler-Wex, C., Walitza, S., Warnke, A., Wewetzer, C. (eds) Neuro-/Psychopharmaka im Kindes- und Jugendalter. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-48624-5_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-48624-5_1

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-48623-8

  • Online ISBN: 978-3-662-48624-5

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation